Medicaid Providers should complete the following survey by May 14, 2024: CMS DUR Annual Survey–Provider PDMP Survey
Background:
The annual CMS Drug Utilization Review (DUR) Survey contains a new, required section of
responses related to the Texas Prescription Drug Monitoring Program (PDMP). This year’s
survey is for data material from Federal Fiscal Year (FFY) 2023 (October 1, 2022, to September 30,
2023).
Key Details:
CMS now requires Medicaid to report data about prescribing providers’ use of PDMPs before
prescribing controlled substances. Texas Medicaid obtains this information from the Texas
State Board of Pharmacy but does not have access to the PDMP data. A voluntary provider
survey created by HHSC will assist HHSC in gathering the required data needed to report on
Texas’s PDMP usage and meet federal reporting requirements for the following DUR Survey
question:
- The percentage of covered providers (as determined pursuant to a process established by the State) who checked the prescription drug history of a covered individual through a PDMP before prescribing a controlled substance to such an individual.
- How this information was obtained (through provider survey, provider attestation, PDMP vendor report, raw PDMP data using the median, or another method).
Action:
HHSC will disseminate the survey across multiple platforms and will collect and analyze the responses. Provider participation in the survey is requested by May 14, 2024.
Link to survey: CMS DUR Annual Survey–Provider PDMP Survey
Contact:
vdp-formulary@hhsc.state.tx.us
Resources:
Newly Required PDMP Data Information for CMS Annual Drug Utilization Review Survey for Federal Fisca